IMARC Group, a leading market research company, has recently released a report titled "Connected Drug Delivery Devices Market Report by Product (Connected Sensors, Integrated Connected Devices), End User (Hospitals and Healthcare Providers, Homecare), Technology (Bluetooth, NFC, and Others), and Region 2024-2032". The study provides a detailed analysis of the industry, including the connected drug delivery devices market share, size, trends and growth forecast. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

The global connected drug delivery devices market size reached US$ 864.4 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 6,879.9 Million by 2032, exhibiting a growth rate (CAGR) of 25.1% during 2024-2032.

Request to Get the Sample Report: https://www.imarcgroup.com/connected-drug-delivery-devices-market/requestsample

Factors Affecting the Growth of the Connected Drug Delivery Devices Industry:

  • Increasing Prevalence of Chronic Diseases:

The rising prevalence of chronic diseases such as diabetes, asthma, and cardiovascular disorders (CVDs) is one of the most significant factors driving the growth of the connected drug delivery devices market. Chronic diseases require ongoing management and consistent medication adherence, which can be challenging for patients. Connected drug delivery devices address these challenges by providing sophisticated solutions that help patients manage their conditions more effectively. Additionally, these devices can send reminders and alerts to patients, reducing the likelihood of missed doses. Besides this, the ability to monitor medication adherence in real-time allows healthcare providers to make timely interventions, potentially improving patient outcomes and reducing complications associated with chronic diseases.

  • Patient Compliance and Adherence:

Improving patient compliance and adherence is a critical factor driving the adoption of connected drug delivery devices. Non-adherence to prescribed medication regimens is a significant issue in healthcare, leading to poor health outcomes, increased hospitalizations, and higher healthcare costs. Connected drug delivery devices offer an effective solution to this problem by incorporating features that promote adherence. These devices can send reminders and alerts to patients to take their medications at the prescribed times, reducing the risk of missed doses. They also provide real-time feedback on medication use, allowing patients to see their adherence patterns and encouraging them to stay on track. Moreover, connected devices can track and record detailed usage data, which can be shared with healthcare providers.

  • Technological Advancements:

Technological advancements are a pivotal factor propelling the growth of the connected drug delivery devices market. The integration of wireless technology, the Internet of Things (IoT), and advanced mobile health applications have significantly enhanced the functionality and appeal of these devices. Innovations in sensors and data analytics allow for precise monitoring of drug delivery and patient adherence, providing valuable insights that can be used to tailor treatment plans. Besides this, the development of user-friendly mobile applications that interface with these devices further enhances patient engagement by providing intuitive platforms for tracking medication use, receiving reminders, and accessing educational resources. Additionally, advancements in data security and privacy measures ensure that patient information is protected, fostering trust in these digital solutions.

Speak to An Analyst: https://www.imarcgroup.com/request?type=report&id=3738&flag=C

Connected Drug Delivery Devices Market Report Segmentation:

By Product:

  • Connected Sensors
    • Connected Inhaler Sensors
    • Connectable Injection Sensors
  • Integrated Connected Devices
    • Connected Inhalation Devices
    • Connected Injection Devices

Connected sensors hold the majority of the market share due to their widespread application in enhancing the functionality and accuracy of drug delivery devices through real-time monitoring and data collection.

By End User:

  • Hospitals and Healthcare Providers
  • Homecare

Hospitals and healthcare accounted for the largest market share because they are primary adopters of advanced medical technologies to improve patient care and streamline medication management processes.

By Technology:

  • Bluetooth
  • NFC
  • Other Technologies

Bluetooth represented the largest segment due to its widespread compatibility, ease of integration with mobile devices, and ability to facilitate real-time communication between drug delivery devices and healthcare systems.

Regional Insights:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America's dominance in the market is attributed to its advanced healthcare infrastructure, high adoption rate of new technologies, and significant investment in healthcare innovation.

Global Connected Drug Delivery Devices Market Trends:

The widespread utilization of these devices for remote patient monitoring, reducing the need for frequent in-person visits and enabling timely interventions, is boosting the market growth. Additionally, the implementation of supportive government policies and funding for digital health solutions, which encourage the adoption of connected drug delivery systems, is fostering the market growth. Besides this, the enhanced patient engagement through real-time data and feedback, improving the overall patient experience and health outcomes, is fostering the market growth. Furthermore, the rising geriatric population, which often requires regular medication, fueling the demand for user-friendly connected drug delivery devices, is acting as another growth-inducing factor.

Top Companies Operated in Connected Drug Delivery Devices Industry:

  • Adherium Ltd.
  • BioCorp Production
  • Cohero Health Inc. (AptarGroup Inc.)
  • Elcam Medical ACS. Ltd
  • Findair Sp. z o. o.
  • Merck KGaA
  • Phillips Medisize (Molex LLC)
  • Propeller Health (Resmed Inc.)
  • Teva Pharmaceutical Industries Ltd.
  • West Pharmaceutical Services Inc.

Key Highlights of the Report:

• Market Performance (2018-2023)
• Market Outlook (2024-2032)
• Market Trends
• Market Drivers and Success Factors
• Impact of COVID-19
• Value Chain Analysis
• Comprehensive mapping of the competitive landscape

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US:

IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145